213 related articles for article (PubMed ID: 24662025)
1. Markers of hepatic regeneration associated with surgical attenuation of congenital portosystemic shunts in dogs.
Tivers MS; Lipscomb VJ; Smith KC; Wheeler-Jones CP; House AK
Vet J; 2014 May; 200(2):305-11. PubMed ID: 24662025
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor (VEGF) and VEGF receptor expression in biopsy samples of liver from dogs with congenital portosystemic shunts.
Tivers MS; Lipscomb VJ; Scase TJ; Priestnall SL; House AK; Gates H; Wheeler-Jones CP; Smith KC
J Comp Pathol; 2012 Jul; 147(1):55-61. PubMed ID: 21996035
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide and toll-like receptor 4 in dogs with congenital portosystemic shunts.
Tivers MS; Lipscomb VJ; Smith KC; Wheeler-Jones CP; House AK
Vet J; 2015 Dec; 206(3):404-13. PubMed ID: 26383860
[TBL] [Abstract][Full Text] [Related]
4. Hepatic gene expression and plasma albumin concentration related to outcome after attenuation of a congenital portosystemic shunt in dogs.
Kummeling A; Penning LC; Rothuizen J; Brinkhof B; Weber MF; van Sluijs FJ
Vet J; 2012 Mar; 191(3):383-8. PubMed ID: 21641243
[TBL] [Abstract][Full Text] [Related]
5. Association between hepatic histopathologic lesions and clinical findings in dogs undergoing surgical attenuation of a congenital portosystemic shunt: 38 cases (2000-2004).
Lee KC; Winstanley A; House JV; Lipscomb V; Lamb C; Gregory S; Jalan R; Mookerjee RP; Brockman DJ
J Am Vet Med Assoc; 2011 Sep; 239(5):638-45. PubMed ID: 21879964
[TBL] [Abstract][Full Text] [Related]
6. Markers of angiogenesis associated with surgical attenuation of congenital portosystemic shunts in dogs.
Tivers MS; House AK; Smith KC; Wheeler-Jones CP; Lipscomb VJ
J Vet Intern Med; 2014; 28(5):1424-32. PubMed ID: 25132501
[TBL] [Abstract][Full Text] [Related]
7. Association of portovenographic findings with outcome in dogs receiving surgical treatment for single congenital portosystemic shunts: 45 cases (2000-2004).
Lee KC; Lipscomb VJ; Lamb CR; Gregory SP; Guitian J; Brockman DJ
J Am Vet Med Assoc; 2006 Oct; 229(7):1122-9. PubMed ID: 17014361
[TBL] [Abstract][Full Text] [Related]
8. Hepatic hepcidin gene expression in dogs with a congenital portosystemic shunt.
Frowde PE; Gow AG; Burton CA; Powell R; Lipscomb VJ; House AK; Mellanby RJ; Tivers MS
J Vet Intern Med; 2014; 28(4):1203-5. PubMed ID: 24962818
[TBL] [Abstract][Full Text] [Related]
9. Hepatic volume measurements in dogs with extrahepatic congenital portosystemic shunts before and after surgical attenuation.
Kummeling A; Vrakking DJ; Rothuizen J; Gerritsen KM; van Sluijs FJ
J Vet Intern Med; 2010; 24(1):114-9. PubMed ID: 20391636
[TBL] [Abstract][Full Text] [Related]
10. Congenital portosystemic shunts in dogs: 46 cases (1979-1986).
Johnson CA; Armstrong PJ; Hauptman JG
J Am Vet Med Assoc; 1987 Dec; 191(11):1478-83. PubMed ID: 3693002
[TBL] [Abstract][Full Text] [Related]
11. Liver size, bodyweight, and tolerance to acute complete occlusion of congenital extrahepatic portosystemic shunts in dogs.
Doran IP; Barr FJ; Hotston Moore A; Knowles TG; Holt PE
Vet Surg; 2008 Oct; 37(7):656-62. PubMed ID: 19134088
[TBL] [Abstract][Full Text] [Related]
12. Serum hyaluronic acid in dogs with congenital portosystemic shunts.
Seki M; Asano K; Sakai M; Kanno N; Teshima K; Edamura K; Tanaka S
J Small Anim Pract; 2010 May; 51(5):260-3. PubMed ID: 20402843
[TBL] [Abstract][Full Text] [Related]
13. Adrenal response to adrenocorticotropic hormone in dogs before and after surgical attenuation of a single congenital portosystemic shunt.
Holford AL; Tobias KM; Bartges JW; Johnson BM
J Vet Intern Med; 2008; 22(4):832-8. PubMed ID: 18647153
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors for neurological signs after attenuation of single congenital portosystemic shunts in 253 dogs.
Strickland R; Tivers MS; Adamantos SE; Harcourt-Brown TR; Fowkes RC; Lipscomb VJ
Vet Surg; 2018 Aug; 47(6):745-755. PubMed ID: 30084495
[TBL] [Abstract][Full Text] [Related]
15. Recombinant hepatocyte growth factor treatment in a canine model of congenital liver hypoplasia.
Kruitwagen HS; Arends B; Spee B; Brinkhof B; van den Ingh TS; Rutten VP; Penning LC; Roskams T; Rothuizen J
Liver Int; 2011 Aug; 31(7):940-9. PubMed ID: 21733083
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Gene Expression of Angiogenic and Regeneration Markers in Cats with Congenital Portosystemic Shunts (CPSS).
Tivers MS; Mirczuk SM; Charlesworth A; Wood L; Barker EN; Lipscomb VJ; Fowkes RC
Vet Sci; 2024 Feb; 11(3):. PubMed ID: 38535834
[TBL] [Abstract][Full Text] [Related]
17. Increased bone morphogenetic protein 7 signalling in the kidneys of dogs affected with a congenital portosystemic shunt.
van Dongen AM; Heuving SM; Tryfonidou MA; van Steenbeek FG; Rothuizen J; Penning LC
Vet J; 2015 May; 204(2):226-8. PubMed ID: 25920772
[TBL] [Abstract][Full Text] [Related]
18. Endogenous benzodiazepine activity in the peripheral and portal blood of dogs with congenital portosystemic shunts.
Aronson LR; Gacad RC; Kaminsky-Russ K; Gregory CR; Mullen KD
Vet Surg; 1997; 26(3):189-94. PubMed ID: 9150556
[TBL] [Abstract][Full Text] [Related]
19. "Hepatic volume measurements in dogs with extrahepatic congenital portosystemic shunts (CPSS) before and after surgical attenuation" by Kummeling et al (2010;24:114-119).
Impellizeri JA
J Vet Intern Med; 2010; 24(3):453; author reply 454. PubMed ID: 20565565
[No Abstract] [Full Text] [Related]
20. Genome-wide based model predicting recovery from portosystemic shunting after liver shunt attenuation in dogs.
Van den Bossche L; van Steenbeek FG; Weber MF; Spee B; Penning LC; van Sluijs FJ; Zomerdijk F; Groot Koerkamp MJA; Rothuizen J; Burgener IA; Kummeling A
J Vet Intern Med; 2018 Jul; 32(4):1343-1352. PubMed ID: 29770973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
